Home/Silver Creek Pharmaceuticals/Karim Dabbagh, PhD

KD

Karim Dabbagh, PhD

President & CEO

Silver Creek Pharmaceuticals

Therapeutic Areas

Neurology Cardiology Nephrology

Silver Creek Pharmaceuticals Pipeline

Drug	Indication	Phase
scp776	Acute Ischemic Stroke	Phase 2

Leadership Team at Silver Creek Pharmaceuticals

Mark Corrigan, MD

Chief Strategic Advisor

Kris Kuchenbecker, PhD

Chief Science and Technology Officer

View full Silver Creek Pharmaceuticals profile